Walleye Trading LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$324,225
-52.4%
13,100
-45.6%
0.00%
-50.0%
Q3 2022$681,000
-41.2%
24,078
-39.5%
0.00%
-50.0%
Q1 2022$1,159,000
+105.5%
39,822
+132.1%
0.00%
+100.0%
Q4 2021$564,000
-13.4%
17,155
+21.7%
0.00%0.0%
Q3 2021$651,000
+133.3%
14,100
+119.1%
0.00%
+100.0%
Q4 2020$279,000
-90.8%
6,435
-88.6%
0.00%
-94.7%
Q2 2020$3,027,000
-32.2%
56,600
-55.0%
0.02%
-44.1%
Q1 2020$4,466,000
-24.5%
125,895
+1.6%
0.03%
-15.0%
Q4 2019$5,916,000
+237.3%
123,900
+128.8%
0.04%
+166.7%
Q3 2019$1,754,000
-26.1%
54,147
+13.8%
0.02%
-28.6%
Q2 2019$2,374,000
+0.6%
47,600
+36.1%
0.02%
+16.7%
Q1 2019$2,359,000
-23.8%
34,972
-47.9%
0.02%
-21.7%
Q4 2018$3,094,000
+57.9%
67,102
+164.1%
0.02%
+130.0%
Q3 2018$1,959,000
+190.7%
25,403
+217.5%
0.01%
+150.0%
Q2 2018$674,000
+13380.0%
8,000
+7900.0%
0.00%
Q2 2017$5,0001000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders